Inhibitors targeting the SUMOylation pathway: A patent review 2012‑2015 (Review)

  • Authors:
    • Yanjun Zhou
    • Chunmei Ji
    • Mengda Cao
    • Miao Guo
    • Wen Huang
    • Weiwei Ni
    • Ling Meng
    • Haiwei Yang
    • Ji‑Fu Wei
  • View Affiliations

  • Published online on: November 1, 2017     https://doi.org/10.3892/ijmm.2017.3231
  • Pages:3-12
Metrics: HTML 0 views | PDF 0 views
0

Abstract

Small ubiquitin‑related modifier (SUMO) proteins bind to the lysine residue of target proteins to produce functionally mature proteins. The abnormal SUMOylation of certain target proteins is associated with diseases including cancer, heart disease, diabetes, arthritis, degenerative diseases and brain ischemia/stroke. Thus, there has been growing appreciation for the potential importance of the SUMO conjugation pathway as a target for treating these diseases. This review introduces the important steps in the reversible SUMOylation pathway. The SUMO inhibitors disclosed in the patents between 2012 and 2015 are divided into different categories according to their mechanisms of action. Certain compounds disclosed in this review have also been reported in other articles for their inhibition of the SUMOylation pathway following screening in cell lines. Although there are few studies using animal models or clinical trials that have used these compounds, the application of bortezomin, a ubiquitylation inhibitor, for treating cancer indicates that SUMO inhibitors may be clinically successful.

Related Articles

Journal Cover

January 2018
Volume 41 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

2016 Impact Factor: 2.341
Ranked #21/128 Medicine Research and Experimental
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zhou, Y., Ji, C., Cao, M., Guo, M., Huang, W., Ni, W. ... Wei, J. (2018). Inhibitors targeting the SUMOylation pathway: A patent review 2012‑2015 (Review). International Journal of Molecular Medicine, 41, 3-12. https://doi.org/10.3892/ijmm.2017.3231
MLA
Zhou, Y., Ji, C., Cao, M., Guo, M., Huang, W., Ni, W., Meng, L., Yang, H., Wei, J."Inhibitors targeting the SUMOylation pathway: A patent review 2012‑2015 (Review)". International Journal of Molecular Medicine 41.1 (2018): 3-12.
Chicago
Zhou, Y., Ji, C., Cao, M., Guo, M., Huang, W., Ni, W., Meng, L., Yang, H., Wei, J."Inhibitors targeting the SUMOylation pathway: A patent review 2012‑2015 (Review)". International Journal of Molecular Medicine 41, no. 1 (2018): 3-12. https://doi.org/10.3892/ijmm.2017.3231